We are live on
!
Find out more
Biogen
BIIB
BIIB
969 hedge funds and large institutions have $58.9B invested in Biogen in 2015 Q4 according to their latest regulatory filings, with 139 funds opening new positions, 331 increasing their positions, 372 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
70% more first-time investments, than exits
New positions opened: 139 | Existing positions closed: 82
5% more funds holding
Funds holding: 923 → 969 (+46)
1% more capital invested
Capital invested by funds: $58.4B → $58.9B (+$503M)
0% more funds holding in top 10
Funds holding in top 10: 37 → 37 (0)
11% less repeat investments, than reductions
Existing positions increased: 331 | Existing positions reduced: 372
24% less call options, than puts
Call options by funds: $1.24B | Put options by funds: $1.63B
Holders
969
Holders Change
+46
Holders Change %
+4.98%
% of All Funds
25.43%
Holding in Top 10
37
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.97%
New
139
Increased
331
Reduced
372
Closed
82
Calls
$1.24B
Puts
$1.63B
Net Calls
-$397M
Net Calls Change
+$181M
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$429M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$150M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
+$147M |
| 4 |
Millennium Management
New York
|
+$122M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$106M |
